|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.83 USD | +0.34% |
|
+4.69% | +36.61% |
| Apr. 19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
| Apr. 01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
Cellebrite DI Ltd. provided revenue guidance for the full year 2022. for the year, the company's revenue is expected to be between $285 and $300 million, representing 16-22% year on year growth.
| 1st Jan change | Capi. | |
|---|---|---|
| +36.61% | 2.43B | |
| +14.09% | 3,189B | |
| +11.00% | 87.18B | |
| +6.51% | 78.95B | |
| -12.92% | 55.02B | |
| +23.70% | 47.3B | |
| +32.92% | 46.79B | |
| -25.15% | 46.35B | |
| +80.89% | 42.08B | |
| -5.92% | 25.86B |
CELLEBRITE DI LTD. 